abstract |
An oligonucleotide that targets a natural NANOG antisense transcript for use as a therapeutic compound, where the oligonucleotide increases the expression of NANOG; where the natural antisense transcript has the nucleic acid sequence as set forth in SEQ ID NO: 2. |